Found 17 matching trials
Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma PHASE2 Single arm phase II study of Chlorambucil in combination with subcutaneous ...
Show More Status
Active Not Recruiting
Location
Créteil Hopital Henri Mondor
Learn More & Join Trial
MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin PHASE1 To determine the efficacy and safety of combined therapy of determined MG41...
Show More Location
Asan Medical Center
Learn More & Join Trial
Effectiveness, Safety & Nurse Management Study of MabThera SC in Patients With Non-Hodgkin's Lymphoma: Real-Life Setting N/A This prospective, open-label, multicenter, observational study will investi...
Show More Location
Multiple Locations
Learn More & Join Trial
Randomised Trial in Waldenstrom's Macroglobulinaemia PHASE2 The purpose of this trial is to assess tolerability and efficacy of the Bor...
Show More Location
Basingstoke & North Hampshire Hospital
Learn More & Join Trial
Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma PHASE2 The purpose of this trial is to evaluate whether a Rituximab plus 2 CdA com...
Show More Location
Universitätsklinikum Graz
Learn More & Join Trial
A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma PHASE3 This randomized, open-label study will compare the efficacy and safety of M...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action PHASE4 The purpose of this study is to find biological response patterns of patien...
Show More Location
Gesundheitszentrum Mariahilf
Learn More & Join Trial
Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2 PHASE1 The ImbruVeRCHOP-Trials is an Investigator-initiated, single-arm, multi-cen...
Show More Location
Charité - Universitätsmedizin Berlin, Hematology, Oncology and Tumor Immunology, Campus Virchow Klinikum
Learn More & Join Trial
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia PHASE1 RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Show More Location
Medizinische Universitaetsklinik I at the University of Cologne
Learn More & Join Trial
Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma PHASE2 This phase II clinical trial aims at evaluating the efficacy and safety of ...
Show More Location
Seoul National University Hospital
Learn More & Join Trial